Document is current
Any future updates will be listed below
-
Authors
Zang, Yi
Shi, Jingjing
Zhao, Guanguan
Tang, Bixi
Liu, Mingliang
Yao, Benqiang
Wang, Gaihong
Pan, Hualing
Yang, Shengsheng
Deng, Rong
Zhao, Yishuang
Zhang, Zhenwei
Guo, Hao-Ran https://orcid.org/0000-0003-1709-7593
Sun, Dan-Dan
Wang, Hanlin https://orcid.org/0000-0003-0443-4378
Gao, Lixin
Yu, Jinghua https://orcid.org/0000-0002-9932-1140
Diao, Xingxing https://orcid.org/0000-0002-6892-0861
Li, Yong
Li, Jia https://orcid.org/0000-0003-3224-001X
Xu, H. Eric https://orcid.org/0000-0002-6829-8144
- License Information
-
More Information
Article History
Received: 20 July 2025
Accepted: 7 May 2026
First Online: 10 June 2026
Competing interests
: Y. Zang, J.S., D.-D.S., L.G., J.L., H.E.X. and Cascade Pharmaceuticals (of which Z.Z. and H.E.X. are co-founders, and G.Z., G.W., H.P., S.Y., R.D. and Y. Zhao are employees) have filed patents on linafexor (PCT/CN2020/085713, PCT/CN2021/121313, US12240841B2 and CN 114315830 B). The remaining authors declare no competing interest.
